Yayınlar & Eserler

Makaleler 67
Tümü (67)
SCI-E, SSCI, AHCI (60)
SCI-E, SSCI, AHCI, ESCI (64)
ESCI (4)
Scopus (63)
TRDizin (13)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 64

1. Distinct Gene Variations Associated with Severity of Infection in COVID-19 Patients

European Academy of Allergy and Clinical Immunology Congress 2026, İstanbul, Türkiye, 12 - 15 Haziran 2026, (Özet Bildiri)

5. Anti İnterferon Alfa Otoantikorlarının COVID-19 Seyrindeki Rolü

II. Viral İnfeksiyonlar ve Bağışıklama Simpozyumu, Ankara, Türkiye, 18 - 20 Eylül 2025, ss.108, (Tam Metin Bildiri) Creative Commons License

6. Vitamin A and Th17/Treg homeostasis in children with cystic fibrosis

European-Respiratory-Society Congress (ERS), Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2025, cilt.66, (Özet Bildiri)

7. Evaluation of immune responses against indigenously developed tetanus and diphtheria toxoid vaccines

19th International Congress of Immunology, Vienna, Avusturya, 17 - 22 Ağustos 2025, ss.4046-4047, (Özet Bildiri)

10. Altered Cytokine Profiles in Behçet’s Disease: Differential Expression of IL-17, IFN-γ, IL-36, IL-37, IL-38 and IL-40

The European Alliance of Associations for Rheumatology Congress 2025, Barselona, İspanya, 11 - 14 Haziran 2025, (Özet Bildiri)

11. POS0583 IL-40: A NOVEL PROINFLAMMATORY B CELL-ASSOCIATED CYTOKINE AND ITS ROLE IN SYSTEMIC SCLEROSIS

European Congress of Rheumatology-EULAR 2025, Barcelona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.783-784, (Özet Bildiri)

15. Anti-drug Antibody Development During Ustekinumab Treatment (P 302)

18th International Congress of Immunology - IUIS 2023, Cape-Town, Güney Afrika, 24 Ekim 2022 - 02 Aralık 2023, (Tam Metin Bildiri)

16. The role of interferon alpha autoantibodies in the progress of COVID-19.

33rd European Congress of Clinical Microbiology & Infectious Diseases, Kobenhavn, Danimarka, 15 - 18 Nisan 2023, (Özet Bildiri)

17. Metformin’in Insan Gingival Fibroblastları Üzerindeki Sitotoksisitesinin In Vitro Değerlendirilmesi

Türk Periodontoloji Derneği 51. Uluslararası Bilimsel Kongresi, Antalya, Türkiye, 6 - 09 Kasım 2022, ss.122, (Özet Bildiri)

18. Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits

II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences, 30 Eylül - 02 Ekim 2022, (Tam Metin Bildiri)

21. Evaluation of Antibody Kinetics in Healthcare Workers (HCWs) of an Istutition in Turkey, Vaccinated With Inactivated COVID-19 Vaccine

32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), Barcelona, İspanya, 23 Nisan 2022, (Tam Metin Bildiri)

27. Serum cytokine levels predicting mortality in COVID-19 patients.

31st European Congress of Clinical Microbiology & Infectious Diseases, Viyana, Avusturya, 9 - 12 Temmuz 2021, (Özet Bildiri)

30. Aluminum hydroxide and calcium phosphate adjuvants in adsorbed tetanus and diphtheria vaccines: Immunologic vs histopathologic effects

Annual Meeting of the American-Association-of-Immunologists - Immunology 2020, Hawaii, Amerika Birleşik Devletleri, 8 - 12 Mayıs 2020, cilt.204, (Özet Bildiri) Sürdürülebilir Kalkınma

31. Neoantigens derived from differential mutations of invasive ductal carcinomas with axillary lymph node metastasis

Annual Meeting of the American-Association-of-Immunologists - Immunology 2020, Hawaii, Amerika Birleşik Devletleri, 8 - 12 Mayıs 2020, cilt.204, (Özet Bildiri)

36. NGS analysis for PDGFRA and ESR1 mutations in a case with testicular seminoma case

Cell-Weizmann Institute of Science Symposium: Next Gen Immunology 2018, Rekhovot, İsrail, 11 - 14 Şubat 2018, (Özet Bildiri)

37. NGS analysis for PDGFRA and ESR1 mutations in a case with testicular seminoma case.

Cell-Weizmann Institute of Science, Next Gen Immunology, 11 - 14 Şubat 2018, (Özet Bildiri)

38. NGS analysis of PDGFRA ans ESR1 mutations in a case with testicular seminoma case

Cell-Weizman Institute of Science Symposium- Next Gen Immunology, Rekhovot, İsrail, 11 - 14 Şubat 2018, (Özet Bildiri)

41. Evaluation of the interaction of gold nanocages with macrophages in raw 264.7 cell line-HBsAg model in vitro

European Biotechnology Congress, Dubrovnik, Hırvatistan, 25 - 27 Mayıs 2017, cilt.256, (Özet Bildiri)

42. Development and characterization of monoclonal antibodies specific for human vascular endothelial growth factor

European Biotechnology Congress, Dubrovnik, Hırvatistan, 25 - 27 Mayıs 2017, cilt.256, (Özet Bildiri)

43. Gold-based Nano-adjuvants

7th IEEE International Conference Nanomaterials - Application and Properties (NAP), Odessa, Ukrayna, 10 - 15 Eylül 2017, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

44. Evaluation of the adjuvant effect of gold nanocages in vitro

International Congress of Immunology (ICI), Melbourne, Avustralya, 21 - 26 Ağustos 2016, cilt.46, ss.1223-1224, (Özet Bildiri)

48. Development and characterization of monoclonal antibodies specific for human leptin

European Biotechnology Congress, Bucharest, Romanya, 7 - 09 Mayıs 2015, cilt.208, (Özet Bildiri)

49. FREQUENCY OF AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IN CHILDREN WITH CHRONIC IMMUNE CYTOPENIAS AND NEWLY DIAGNOSED LYMPHOMA

20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.557, (Özet Bildiri)

51. Biocompatible thermoresponsive PEGMA nanoparticles crosslinked with cleavable disulfide based crosslinker for dual drug release

247th National Spring Meeting of the American-Chemical-Society (ACS), Texas, Amerika Birleşik Devletleri, 16 - 20 Mart 2014, cilt.247, (Özet Bildiri)

52. Expression of CD47 in bladder cancer

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri) Sürdürülebilir Kalkınma

53. High Th17/Treg ratio in rheumatic heart disease

Congress of the European-Society-of-Cardiology (ESC), Amsterdam, Hollanda, 31 Ağustos - 04 Eylül 2013, cilt.34, ss.697-698, (Özet Bildiri)

54. Acute cytokine responses of human monocytes to Toxoplasma gondii

100th Annual Meeting of the American-Association-of-Immunologists, Hawaii, Amerika Birleşik Devletleri, 3 - 07 Mayıs 2013, cilt.190, (Özet Bildiri)

55. Acute Cytokine Reponses of human monocytes to Toxoplasma gondii, P3104

104th American Immunology Annual Meeting of AAI, Honolulu, Hawaii, Amerika Birleşik Devletleri, 1 - 04 Mayıs 2013, cilt.190, ss.125, (Tam Metin Bildiri)

56. Effects of acute doxorubicin exposure on caspase-mediated apoptosis in cardiomyocytes.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

57. EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC)

37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.277, (Özet Bildiri)

58. Effects of interleukin-33 on phagocytosis and nitric oxide synthesis in macrophages

European Congress of Immunology, Glasgow, İngiltere, 5 - 08 Eylül 2012, cilt.137, ss.266, (Özet Bildiri)

59. An investigation for IL-6 responses in patients with pandemic influenza A (H1N1) infection

99th Annual Meeting of the American-Association-of-Immunologists, Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Mayıs 2012, cilt.188, (Özet Bildiri)

61. Differential immunomodulatory activity of soluble beta glucans from barley and yeast in antigen specific humoral immune responses

Annual Congress of the British-Society-of-Immunology, Glasgow, İngiltere, 17 - 21 Kasım 2008, cilt.125, ss.141, (Özet Bildiri)

62. Experimental diabetes treated with stobadine: effects on kidney oxidative/nitrosative stress parameters

43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, Hollanda, 18 - 21 Eylül 2007, cilt.50, (Özet Bildiri) Sürdürülebilir Kalkınma

63. Stobadin prevents doxorubicin-induced apoptosis by inhibiting caspase 3 in P815 cells

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.172-173, (Özet Bildiri)
Kitaplar 8

1. İmmünogenetik

Moleküler Biyoloji ve Genetik, Solak Mustafa, Editör, TÜBA, Ankara, ss.331-362, 2023

2. Biotechnological Approaches in Maintenance of a Healthy Immune System for Protection Against Diseases

Nanotechnology Applications in Health and Environmental Sciences, Necdet Sağlam,Feza Korkusuz,Ram Prasad, Editör, Springer Nature, Zug, ss.1-423, 2021

3. BIOTECHNICAL APPROACHES IN MAINTENANCE OF A HEALTHY IMMUNE SYSTEM FOR PROTECTION AGAINST DISEASES

NANOTECHNOLOGY APPLICATIONS IN HEALTH AND ENVIRONMENTAL SCIENCES, NECDET SAGLAM, FEZA KORKUSUZ, RAM PRASAD, Editör, Springer Nature, ss.291-298, 2021

4. COVID-19 ve B Lenfosit Cevabı

İmmünoloji ve COVID-19, Aysegul Atak Yucel, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.22-27, 2020 Sürdürülebilir Kalkınma

5. COVID-19 ve T Lenfosit Cevapları

İMMÜNOLOJİ VE COVID-19, Atak Yücel Ayşegül, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.9-14, 2020 Sürdürülebilir Kalkınma

6. Covid-19 ve B Lenfosit Cevabı

Covid-19: İmmünoloji ve Covid-19, AYŞEGÜL ATAK YÜCEL, Editör, TÜRKİYE KLİNİKLERİ, Ankara, ss.22-27, 2020

7. Covid-19 ve T Lenfosit Cevapları

Covid-19: İmmünoloji ve Covid-19, Ayşegül ATAK YÜCEL, Editör, Türkiye Klinikleri, Ankara, ss.9-14, 2020

8. İntestinal Homeostaz: Mikrobiyota ve İmmün Sistem Etkileşimleri

Mikrobiyota Immunolojisi, Resul Karakuş, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.70-75, 2018 Sürdürülebilir Kalkınma
Metrikler

Yayın

140

Yayın (WoS)

89

Yayın (Scopus)

64

Atıf (WoS)

843

H-İndeks (WoS)

15

Atıf (Scopus)

885

H-İndeks (Scopus)

16

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

37

Fikri Mülkiyet

4

Tez Danışmanlığı

9

Açık Erişim

17
BM Sürdürülebilir Kalkınma Amaçları